Skip to main content
Reuters home
World
Business
Legal
Markets
Breakingviews
Technology
Investigations
More
My View
Register
47 results
Business
Salesforce cuts forecast on lower IT spending, forex hit
, article with image
August 24, 2022
Future of Health
Biotech stocks pin bounce back hopes on M&A boost
, article with image
August 12, 2022
Business
CVS raises annual COVID-related revenue forecast to $3 billion
, article with image
August 3, 2022
Markets
PerkinElmer divests three business units in $2.45 bln deal
, article with image
August 1, 2022
Business
Merck profit tops Wall Street view on strong Keytruda sales
, article with image
July 28, 2022
Business
Abbott aims to recapture baby formula market share
, article with gallery
July 20, 2022
Gallery
Business
Walgreens keeps forecast as waning COVID vaccine demand weighs
, article with gallery
June 30, 2022
Gallery
Healthcare & Pharmaceuticals
U.S. FDA advisers recommend change to COVID vaccine composition for fall
, article with video
June 29, 2022
Video
Business
Bruised investors focus on biotechs with drugs closer to market
, article with image
June 27, 2022
Healthcare & Pharmaceuticals
U.S. COVID vaccines start to roll out for young children
, article with video
June 22, 2022
Video
Business
Amylyx's ALS drug would not be cost effective if priced around $170,000- ICER
June 14, 2022
Business
Amylyx gets first approval for ALS drug from Canada
June 13, 2022
World
U.S. expects 300,000 more Jynneos doses as monkeypox cases jump to 45
, article with image
June 10, 2022
Business
Surging drug prices targeted in U.S. study of pharmacy giants
, article with image
June 7, 2022
Business
Abbott developing test for monkeypox
, article with image
May 26, 2022
Business
Medtronic's profit forecast bogged down by supply chain issues
May 26, 2022
Business
Abbott completes India recall of baby formula products imported from U.S.
, article with gallery
May 20, 2022
Gallery
Legal
FDA declines to authorize common antidepressant as COVID treatment
, article with image
May 16, 2022
Business
FDA declines to authorize common antidepressant as COVID treatment
, article with image
May 16, 2022
Healthcare & Pharmaceuticals
Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm
, article with video
May 4, 2022
Video
1 to 20 of 47